Immune cell toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosis

Cell Reports

Volumn 7, Issue 4, 2014, Pages 1116-1129

  Vila, Isabelle K ^a,b,c   Badin, Pierre Marie ^a,b,c   Marques, Marie Adeline ^a,b,c   Monbrun, Laurent ^a,b,c   Lefort, Corinne ^a,b,c   Mir, Lucile ^a,b,c   Louche, Katie ^a,b,c   Bourlier, Virginie ^a,b,c   Roussel, Balbine ^a,b,c   Gui, Philippe ^b,c   Grober, Jacques ^d,e   Štich, Vladimír ^f   Rossmeislová, Lenka ^f   Zakaroff Girard, Alexia ^b,c   Bouloumié, Anne ^b,c   Viguerie, Nathalie ^a,b,c   Moro, Cedric ^a,b,c   Tavernier, Geneviève ^a,b,c   Langin, Dominique ^a,b,c,g  

^a INSERM   (France)

^b Departments of Clinical Biochemistry and Sports Medicine   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d boulevard Jeanne d'Arc   (France)

^e UNIVERSITÉ DE BOURGOGNE   (France)

^f CHARLES UNIVERSITY   (Czech Republic)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; LIPOPOLYSACCHARIDE; TLR4 PROTEIN, HUMAN; TLR4 PROTEIN, MOUSE; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1 ANTIBODY; UNCLASSIFIED DRUG;

ADIPOSE TISSUE FIBROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTOXEMIA; EX VIVO STUDY; FIBROSIS; IMMUNOCOMPETENT CELL; IN VIVO STUDY; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; C3H MOUSE; DISEASE MODEL; GENETICS; HUMAN; INFLAMMATION; LIPID DIET; METABOLISM; PATHOLOGY; PHYSIOLOGY; CELL DEATH; CELL FUNCTION; CELL METABOLISM; DRUG EFFICACY; DRUG MECHANISM; HEMATOPOIETIC CELL; HUMAN TISSUE; PATHOGENESIS;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; FIBROSIS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C3H; OBESITY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84901263952     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.062     Document Type: Article

References (43)

1. Aoyama T., Paik Y.H., Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol. Res. Pract. 2010, 2010:192543.
2. Biernacka A., Dobaczewski M., Frangogiannis N.G. TGF-β signaling in fibrosis. Growth Factors 2011, 29:196-202.
3. Bourlier V., Sengenès C., Zakaroff-Girard A., Decaunes P., Wdziekonski B., Galitzky J., Villageois P., Esteve D., Chiotasso P., Dani C., Bouloumié A. TGFbeta family members are key mediators in the induction of myofibroblast phenotype of human adipose tissue progenitor cells by macrophages. PLoS ONE 2012, 7:e31274.
4. Campbell M.T., Hile K.L., Zhang H., Asanuma H., Vanderbrink B.A., Rink R.R., Meldrum K.K. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J. Surg. Res. 2011, 168:e61-e69.
5. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., Coupaye M., Pelloux V., Hugol D., Bouillot J.L., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286.
6. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
7. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., Wang S., Fortier M., Greenberg A.S., Obin M.S. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 2005, 46:2347-2355.
8. Divoux A., Tordjman J., Lacasa D., Veyrie N., Hugol D., Aissat A., Basdevant A., Guerre-Millo M., Poitou C., Zucker J.D., et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 2010, 59:2817-2825.
9. Divoux A., Moutel S., Poitou C., Lacasa D., Veyrie N., Aissat A., Arock M., Guerre-Millo M., Clément K. Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J. Clin. Endocrinol. Metab. 2012, 97:E1677-E1685.
10. Gandotra S., Le Dour C., Bottomley W., Cervera P., Giral P., Reznik Y., Charpentier G., Auclair M., Delépine M., Barroso I., et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 2011, 364:740-748.
11. Henegar C., Tordjman J., Achard V., Lacasa D., Cremer I., Guerre-Millo M., Poitou C., Basdevant A., Stich V., Viguerie N., et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 2008, 9:R14.
12. Horng T., Hotamisligil G.S. Linking the inflammasome to obesity-related disease. Nat. Med. 2011, 17:164-165.
13. Li M., Matsunaga N., Hazeki K., Nakamura K., Takashima K., Seya T., Hazeki O., Kitazaki T., Iizawa Y. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol. Pharmacol. 2006, 69:1288-1295.
14. Keophiphath M., Achard V., Henegar C., Rouault C., Clément K., Lacasa D. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol. Endocrinol. 2009, 23:11-24.
15. Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N., Zhang B.B., Bonaldo P., Chua S., Scherer P.E. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 2009, 29:1575-1591.
16. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., Schraw T., Durand J.L., Li H., Li G., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 2007, 117:2621-2637.
17. Klimcakova E., Roussel B., Kovacova Z., Kovacikova M., Siklova-Vitkova M., Combes M., Hejnova J., Decaunes P., Maoret J.J., Vedral T., et al. Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia 2011, 54:876-887.
18. Klimcáková E., Roussel B., Márquez-Quiñones A., Kovácová Z., Kováciková M., Combes M., Siklová-Vítková M., Hejnová J., Srámková P., Bouloumié A., et al. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. J. Clin. Endocrinol. Metab. 2011, 96:E73-E82.
19. Kusminski C.M., Holland W.L., Sun K., Park J., Spurgin S.B., Lin Y., Askew G.R., Simcox J.A., McClain D.A., Li C., Scherer P.E. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat. Med. 2012, 18:1539-1549.
20. Kwon E.Y., Shin S.K., Cho Y.Y., Jung U.J., Kim E., Park T., Park J.H., Yun J.W., McGregor R.A., Park Y.B., Choi M.S. Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity. BMC Genomics 2012, 13:450.
21. Lacasa D., Taleb S., Keophiphath M., Miranville A., Clement K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 2007, 148:868-877.
22. Medina-Gomez G., Gray S.L., Yetukuri L., Shimomura K., Virtue S., Campbell M., Curtis R.K., Jimenez-Linan M., Blount M., Yeo G.S., et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 2007, 3:e64.
23. Morris D.L., Singer K., Lumeng C.N. Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14:341-346.
24. Nguyen M.T., Favelyukis S., Nguyen A.K., Reichart D., Scott P.A., Jenn A., Liu-Bryan R., Glass C.K., Neels J.G., Olefsky J.M. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 2007, 282:35279-35292.
25. Nguyen A.T., Mandard S., Dray C., Deckert V., Valet P., Besnard P., Drucker D.J., Lagrost L., Grober J. Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: Involvement of the glucagon-like peptide 1 (GLP1) pathway. Diabetes 2013, 63:471-482.
26. Pajvani U.B., Trujillo M.E., Combs T.P., Iyengar P., Jelicks L., Roth K.A., Kitsis R.N., Scherer P.E. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat. Med. 2005, 11:797-803.
27. Pardo A., Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc. Am. Thorac. Soc. 2006, 3:383-388.
28. Poggi M., Bastelica D., Gual P., Iglesias M.A., Gremeaux T., Knauf C., Peiretti F., Verdier M., Juhan-Vague I., Tanti J.F., et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia 2007, 50:1267-1276.
29. Rossmeislová L., Malisová L., Kracmerová J., Tencerová M., Kovácová Z., Koc M., Siklová-Vítková M., Viquerie N., Langin D., Stich V. Weight loss improves the adipogenic capacity of human preadipocytes and modulates their secretory profile. Diabetes 2013, 62:1990-1995.
30. Saberi M., Woods N.B., de Luca C., Schenk S., Lu J.C., Bandyopadhyay G., Verma I.M., Olefsky J.M. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 2009, 10:419-429.
31. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., Schwabe R.F. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007, 13:1324-1332.
32. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
33. Spencer M., Yao-Borengasser A., Unal R., Rasouli N., Gurley C.M., Zhu B., Peterson C.A., Kern P.A. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E1016-E1027.
34. Stramer B.M., Mori R., Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J. Invest. Dermatol. 2007, 127:1009-1017.
35. Strissel K.J., Stancheva Z., Miyoshi H., Perfield J.W., DeFuria J., Jick Z., Greenberg A.S., Obin M.S. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 56:2910-2918.
36. Sun K., Tordjman J., Clément K., Scherer P.E. Fibrosis and adipose tissue dysfunction. Cell Metab. 2013, 18:470-477.
37. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., Prada P.O., Hirabara S.M., Schenka A.A., Araújo E.P., Vassallo J., Curi R., Velloso L.A., Saad M.J. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56:1986-1998.
38. Viguerie N., Montastier E., Maoret J.J., Roussel B., Combes M., Valle C., Villa-Vialaneix N., Iacovoni J.S., Martinez J.A., Holst C., et al. Determinants of human adipose tissue gene expression: impact of diet, sex, metabolic status, and cis genetic regulation. PLoS Genet. 2012, 8:e1002959.
39. Virtue S., Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol. 2008, 6:e237.
40. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
41. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 2010, 30:245-257.
42. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
43. Zeyda M., Gollinger K., Kriehuber E., Kiefer F.W., Neuhofer A., Stulnig T.M. Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. Int. J. Obes. (Lond.) 2010, 34:1684-1694.